A. Herrero-Ambrosio

Influence of statin treatment in a cohort of patients admitted for COVID-19

J. R. Rey, J. L. Merino Llorens, J. Caro-Codón, 2021, Medicina Clínica (English Edition).

Influence of statin treatment in a cohort of patients admitted for COVID-19

J. R. Rey, J. L. Merino Llorens, J. Caro-Codón, 2022, Medicina clinica.

Influence of statin treatment in a cohort of patients admitted for COVID-19

J. R. Rey, J. L. Merino Llorens, J. Caro-Codón, 2022, Medicina clinica.

Development of a telematic pharmaceutical care app (Haemoassist) for multidisciplinary follow-up of patients with congenital coagulopathies.

V. Jiménez‐Yuste, E. Rodríguez‐Merchán, M. Álvarez‐Román, 2022, Expert Review of Hematology.

Intraocular minocycline for the treatment of ocular pythiosis

A. Herrero-Ambrosio, A. Boto-de-los-Bueis, Fátima Ros Castellar, 2017 .

Objective quantification of adherence to prophylaxis in haemophilia patients aged 12 to 25years and its potential association with bleeding episodes.

E. Rodríguez‐Merchán, J. Romero-Garrido, A. Herrero-Ambrosio, 2016, Thrombosis research.

Analysis of antiretroviral therapy modification in routine clinical practice in the management of HIV infection

I. Jiménez-Nácher, J. González-García, F. Moreno-Ramos, 2016, European journal of hospital pharmacy. Science and practice.

Perception survey on the value of the hospital pharmacist at the emergency department.

M. Quintana-Díaz, C. Maroun-Eid, A. Herrero-Ambrosio, 2017, Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria.

Spanish Rheumatology Society and Hospital Pharmacy Society Consensus on recommendations for biologics optimization in patients with rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis

E. Martı́n-Mola, I. González-Álvaro, R. Sanmartí, 2014, Rheumatology.

Consensus on recommendations for biologics optimization in patients with rheumatoid arthritis , ankylosing spondylitis and psoriatic arthritis

Jesús, Rosário, E. Martı́n-Mola, 2015 .

Real-world Performance of a New Strategy for Off-Label Use of Guselkumab in Moderate to Severe Psoriasis: Super-Responder Patients as the Epitome of Efficacy and Optimisation

A. Herrero-Ambrosio, A. Mayor-Ibarguren, M. González-Fernández, 2023, Clinical drug investigation.